End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.88 CNY | -0.75% | -5.08% | -6.70% |
Jan. 19 | Tasly Pharmaceutical Gets Nod to Trial Stem Cell Therapy | MT |
Dec. 29 | ShuYu Civilian Pharmacy Corp., Ltd. Scraps Plan to Buy Stake in Tasly Pharmaceutical's Two Units | CI |
Sales 2023 * | 9.19B 1.27B | Sales 2024 * | 9.94B 1.38B | Capitalization | 23.63B 3.27B |
---|---|---|---|---|---|
Net income 2023 * | 1.22B 168M | Net income 2024 * | 1.35B 187M | EV / Sales 2023 * | 2.37 x |
Net cash position 2023 * | 1.86B 258M | Net cash position 2024 * | 4.35B 602M | EV / Sales 2024 * | 1.94 x |
P/E ratio 2023 * |
19.7
x | P/E ratio 2024 * |
17.7
x | Employees | 9,183 |
Yield 2023 * |
1.64% | Yield 2024 * |
1.41% | Free-Float | 49.13% |
1 day | -0.75% | ||
1 week | -5.08% | ||
Current month | -5.87% | ||
1 month | -2.58% | ||
3 months | -5.64% | ||
6 months | +9.37% | ||
Current year | -6.70% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Su
CEO | Chief Executive Officer | 61 | 18-04-15 |
Jie Wei
DFI | Director of Finance/CFO | 47 | 18-07-08 |
Ying Zhao
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Meng Jiang
BRD | Director/Board Member | 60 | 07-08-16 |
Nai Feng Wu
BRD | Director/Board Member | 72 | 05-09-08 |
Kai Jing Yan
CHM | Chairman | 45 | 14-03-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 36 M€ | +4.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 15.88 | -0.75% | 14,260,740 |
24-03-27 | 16 | -0.81% | 10,753,000 |
24-03-26 | 16.13 | 0.00% | 11,370,680 |
24-03-25 | 16.13 | -1.77% | 13,151,300 |
24-03-22 | 16.42 | -1.85% | 14,267,910 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.70% | 3.29B | |
+23.32% | 5.39B | |
-12.48% | 4.67B | |
-16.43% | 2.6B | |
-2.41% | 2.52B | |
-7.97% | 1.7B | |
+24.37% | 1.63B | |
-8.02% | 1.61B | |
-4.40% | 1.56B | |
-8.51% | 1.41B |